搜尋結果
2021年3月9日 · Haematologists from the University of Hong Kong (HKU) have reported initial success with chimeric antigen receptor (CAR) T-cell therapy, treating the first patient in Hong Kong in May 2020 in a global lymphoma trial and another leukaemia patient in October 2020 in
SANDOZ HONG KONG LIMITED. Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical need. Our ambition is to be the world's leading and most valued generics company.
- Rm 30-101, 30/F, The Gateway Tower 515 Canton RdTsim Sha TsuiHong Kong
- 2881 5811
Dosage/Direction for Use. SC Starting dose: 75 mg once every 2 wk. Alternative starting dose for patients who prefer less frequent dosing is 300 mg once every 4 wk (mthly). Max: 150 mg every 2 wk. Click to view Praluent detailed prescribing information.
Dosage/Direction for Use. SC 210 mg once mthly for 12 mth. Administer as 2 SC inj (105 mg each) into abdomen, thigh, or upper arm. After 1st inj, immediately give 2nd inj but at a different site. Click to view Evenity detailed prescribing information.
Dosage/Direction for Use. Adult & childn >12 yr Apply a thin layer of gel on small hyperpigmented surfaces. Childn Apply once daily for 10-15 days, only on the stain & continue the treatment w/ 2 daily applications, 1 in the morning & another at night. Click to view Licoforte detailed prescribing information.
Dosage/Direction for Use. SC For initial 400 mg dose, administer two 200-mg inj consecutively in different inj sites. For initial 600 mg dose, administer two 300-mg inj consecutively in different inj sites. Atopic dermatitis Adult Initially 600 mg, followed by 300 mg every other wk. Adolescent 12-17 yr, weighing ≥60 kg Initially 600 mg ...
Dosage/Direction for Use. IM Recommended dose: 0.5 mL of reconstituted vaccine. Pre-exposure prophylaxis Immunocompetent individual or individual w/ decreased immunity Conventional regimen: 1 dose on day 0, 7, & 21 or 28. Immunocompetent individual 1-wk regimen: 1 dose on day 0 & 7. Post-exposure prophylaxis Non-immunised subject or individual ...
